S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q2 2025

Deep Track Capital

Periodo: Q2 2025 · Depositato: 2025-08-14
Vedi su SEC EDGAR
AUM
$3.12B
Valore totale del portafoglio
Posizioni
66
Titoli dichiarati
Prima Posizione
GH
7.1% $221.2M
Var. Trimestrali
+7 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2025-08-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
GHGUARDANT HEALTH INC$221.2M7.09%$52.04$167.98+222.8%
7.1%
IONSIONIS PHARMACEUTICALS INC$193.3M6.20%$39.51$81.80+107.0%
6.2%
PTGXPROTAGONIST THERAPEUTICS INC$179.4M5.75%$55.27$131.62+138.1%
5.8%
DVAXDYNAVAX TECHNOLOGIES CORP$176.5M5.66%
5.7%
INSMINSMED INC$176.1M5.65%$100.64$111.60+10.9%
5.7%
AKROAKERO THERAPEUTICS INC$162.3M5.21%
5.2%
IMVTIMMUNOVANT INC$152.0M4.87%$16.00$38.79+142.4%
4.9%
OCULOCULAR THERAPEUTIX INC$132.7M4.25%$9.28$9.64+3.9%
4.3%
APLSAPELLIS PHARMACEUTICALS INC$121.2M3.89%$17.31
3.9%
CYTKCYTOKINETICS INC$120.6M3.87%$33.04$86.49+161.8%
3.9%
GPCRSTRUCTURE THERAPEUTICS INC$106.5M3.41%$20.74$53.45+157.7%
3.4%
ETNB89BIO INC$93.3M2.99%
3.0%
AXSMAXSOME THERAPEUTICS INC$83.7M2.68%$104.39$244.31+134.0%
2.7%
VRDNVIRIDIAN THERAPEUTICS INC$75.2M2.41%$13.98$19.40+38.8%
2.4%
TARSTARSUS PHARMACEUTICALS INC$70.9M2.27%$40.51$65.44+61.5%
2.3%
PCVXVAXCYTE INC$69.9M2.24%$32.51$58.39+79.6%
2.2%
NRIXNURIX THERAPEUTICS INC$69.1M2.22%$11.39$23.97+110.5%
2.2%
GERNGERON CORP$60.6M1.94%$1.41$1.36-3.5%
1.9%
IMCRIMMUNOCORE HLDGS PLC$56.5M1.81%$31.38$32.50+3.6%
1.8%
RAREULTRAGENYX PHARMACEUTICAL IN$49.1M1.57%$36.36$33.47-8.0%
1.6%
MAZEMAZE THERAPEUTICS INC$48.5M1.55%$12.27$31.26+154.8%
1.6%
ANIPANI PHARMACEUTICALS INC$45.7M1.46%$65.25$86.03+31.9%
1.5%
XENEXENON PHARMACEUTICALS INC$42.3M1.36%$31.30$60.96+94.8%
1.4%
DNTHDIANTHUS THERAPEUTICS INC$41.6M1.33%$18.63$94.34+406.4%
1.3%
CLDXCELLDEX THERAPEUTICS INC NEW$40.7M1.31%$20.35$38.37+88.5%
1.3%
BBIOBRIDGEBIO PHARMA INC$38.9M1.25%$43.18$77.19+78.8%
1.3%
AUTLAUTOLUS THERAPEUTICS PLC$38.4M1.23%$2.28$1.58-30.7%
1.2%
MTSRMETSERA INC$31.1M1.00%
1.0%
TERNTERNS PHARMACEUTICALS INC$28.0M0.90%$3.73
0.9%
TECXTECTONIC THERAPEUTIC INC$27.9M0.89%$19.87$37.93+90.9%
0.9%

Attività Trimestre su Trimestre

Q2 2025 vs. Q1 2025

Nuove Posizioni (7)

TickerEmittenteNozionaleDal Deposito
AXSMAXSOME THERAPEUTICS INC$83.7M+134.0%
JBIOJADE BIOSCIENCES INC$25.1M
MRUSMERUS N V$14.5M
CDTXCIDARA THERAPEUTICS INC$12.2M
CBIOCRESCENT BIOPHARMA INC.$7.3M
CNTACENTESSA PHARMACEUTICALS PLC$6.6M
RAPTRAPT THERAPEUTICS INC$6.0M

Posizioni Chiuse (8)

TickerEmittenteNozionale
ITCIINTRA-CELLULAR THERAPIES INC$263.8M
AMGNAMGEN INC$35.2M
EWTXEDGEWISE THERAPEUTICS INC$30.8M
DYNDYNE THERAPEUTICS INC$20.9M
LKFTGALAPAGOS NV$18.6M
SAGESAGE THERAPEUTICS INC$16.2M
RAPTRAPT THERAPEUTICS INC$7.3M
BEAMBEAM THERAPEUTICS INC$6.2M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
INSMINSMED INC$156.7M+586.9%+10.9%
PCVXVAXCYTE INC$41.6M+186.7%+79.6%
BCYCBICYCLE THERAPEUTICS PLC$1.9M+56.9%
APLSAPELLIS PHARMACEUTICALS INC$11.8M+40.0%
XENEXENON PHARMACEUTICALS INC$8.7M+35.0%+94.8%
TERNTERNS PHARMACEUTICALS INC$12.6M+34.4%
ORKAORUKA THERAPEUTICS INC$6.7M+32.8%
IMCRIMMUNOCORE HLDGS PLC$14.6M+27.5%+3.6%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SEPNSEPTERNA INC$-9.8M-93.6%
RAPPRAPPORT THERAPEUTICS INC$-3.5M-78.5%
SRPTSAREPTA THERAPEUTICS INC$-53.0M-71.1%
KRROKORRO BIO INC$-11.8M-68.2%
BBIOBRIDGEBIO PHARMA INC$-57.9M-67.9%+78.8%
OKURONKURE THERAPEUTICS INC$-1.8M-65.6%
SRPTSAREPTA THERAPEUTICS INC$-49.7M-50.0%
ZURAZURA BIO LTD$-2.4M-47.4%
Torna agli Hedge Fund